ePT--the Electronic Newsletter of Pharmaceutical Technology, Dec 6, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ePT--the Electronic Newsletter of Pharmaceutical Technology, Dec 6, 2012
News
Ranbaxy Issues Voluntary Recall of Atorvastatin Due to Quality Issues
By Patricia Van Arnum
The company issues voluntary recall of certain lots due to possible contamination with small glass particles.
EMA Publishes Plan to Deal with Supply Shortages
By Stephanie Sutton
The European Medicines Agency has published a plan to help Europe?s regulatory network prevent, mitigate and manage shortages of important medicines following manufacturing problems.
US Supreme Court to Hear Myriad Genetics' Gene Patentability Case
By Patricia Van Arnum
Myriad Genetics reports that the US Supreme Court has granted certiorari agreeing to hear the company's gene patentability case.
Lilly Releases Corporate Responsibility Update
By Amy Ritter
Eli Lilly released its annual report containing updates on progress and new initiatives in corporate responsibility.
Week of December 3, 2012: Biogen Idec Opens New RTP Facility; Tekmira, Marina Biotech Enter into License Agreement for UNA Technology; and More
Biogen Idec Opens New RTP Facility; Tekmira, Marina Biotech Enter into License Agreement for UNA Technology; and More.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here